Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2004
10/20/2004EP1469079A1 Carbonly reductases, polynucleotides comprising DNA encoding the same, methods for producing the same,and methods for producing optically active alcohol utilizing the same
10/20/2004EP1469066A2 Glycosidase enzymes
10/20/2004EP1468968A1 Biocatalyst containing a laccase
10/20/2004EP1468392A2 Method for binding site identification using a multi-scale approach
10/20/2004EP1468284A2 Method for measuring intracellular atp and/or gene expression
10/20/2004EP1468093A1 Fermentation of pentose sugars
10/20/2004EP1468092A2 Pim-3 kinase as a target for type 2 diabetes mellitus
10/20/2004EP1468085A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
10/20/2004EP1468084A1 Lipolytic enzyme variants and method for their production
10/20/2004EP1468083A1 Enzymes coated with ionic liquid
10/20/2004EP1468082A1 Crystal structure of phosphodiesterase 5 and use thereof
10/20/2004EP1467629A1 Granulates containing feed-enzymes
10/20/2004EP1467616A2 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
10/20/2004EP1467615A1 Methods to engineer mammalian-type carbohydrate structures
10/20/2004EP1232252A4 Reversibly inactivated acidified plasmin
10/20/2004EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/20/2004EP0967271B1 Novel carbonyl reductase, gene that encodes the same, and method of utilizing these
10/20/2004EP0964929B1 Mismatch endonucleases and uses thereof in identifying mutations in targeted polynucleotide strands
10/20/2004EP0886644B1 Long wavelength engineered fluorescent proteins
10/20/2004EP0885285B1 Detergent compositions comprising proteases and improved amylases
10/20/2004EP0880590B1 Esterases
10/20/2004EP0859050B1 Alkaline protease, process for the production thereof, use thereof, and microorganism producing the same
10/20/2004EP0771214B1 Treatment and prevention of helicobacter infection
10/20/2004EP0739416A4 Enzyme based bioremediation
10/20/2004EP0722461B1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
10/20/2004EP0675949B1 Recombinant lipase and alpha-amylase variants
10/20/2004EP0668906B1 Method for producing polypeptide via bacterial fermentation
10/20/2004EP0631620B1 Mutagenesis and selection methoden in the same host cells
10/20/2004EP0610517B1 Dna coding for decarbamylase improved in thermostability and use thereof
10/20/2004CN1539020A Structure-based drug design methods for idenfitying D-ALA-D-ALA ligase inhibitors as antibacterial drugs
10/20/2004CN1539018A Surface expression vectors having pgs BCA the gene coding poly-gamma-glutamate synthetase, and method for expression of target protein at the surface of microorganism using the vector
10/20/2004CN1539017A Saponin-digesting enzymes, genes there of and soyasapogenol B mass procution system
10/20/2004CN1539016A sd1 gene participating in plant semidwarfing and ultilization thereof
10/20/2004CN1539011A Carbohydrates and polyols for dissolving protein crystal
10/20/2004CN1537939A Method for producing recombinaton urokinase
10/20/2004CN1537938A New earthoworm plasmin and its preparation method
10/20/2004CN1172003C Method for producing N-acetylneuraminic acid
10/20/2004CN1172000C Novel recombinant tissue type plasminogen activating enzyme and its preparation method
10/20/2004CN1171995C Assay for the diagnosis of schizophrenia based on a new peptide
10/20/2004CN1171994C Process for producing pepsase
10/20/2004CN1171993C Novel genes coding amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and their use
10/20/2004CN1171992C Process for preparing L-proline-4-position hydroxylase
10/20/2004CN1171870C Inhibitors of cysteine protease
10/19/2004US6806401 OAR polynucleotides, polypeptides and their use in PHA production in plants
10/19/2004US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent
10/19/2004US6806254 An isolated polynucleotide containing a nucleotide sequence with a specific sequence, translated protein coding protion, mature protein coding protion, extracellular portion or the active domain, codes a polypeptide
10/19/2004US6806085 2-deoxyglucose-6-phosphate (2-DOG-6-P) phosphatase DNA sequences as selection marker in plants
10/19/2004US6806076 Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
10/19/2004US6806074 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
10/19/2004US6806073 For therapeutic, diagnostic, and pharmacogenomic applications
10/19/2004US6806072 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/19/2004US6806071 Glutathione S-transferase
10/19/2004US6806070 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents
10/19/2004US6806068 Nucleotide sequences which encode the pfk gene
10/19/2004US6806063 Protein conjugate for use in the treatment of blood disorder
10/19/2004US6806060 Methods for the identification of inhibitors of threonine synthase as antibiotics
10/19/2004US6806059 Nucleotide sequences coding enzymatic polypeptide for use innthe treatment of asthma, and for use in laundry detergent and stain removers
10/19/2004US6805863 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
10/19/2004CA2315949C Novel plant-derived map kinase kinase
10/19/2004CA2282734C Aminopeptidase derived from bacillus licheniformis and process for preparation of natural type proteins
10/19/2004CA1341459C Modified fibrinolytic enzymes
10/18/2004CA2426115A1 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
10/14/2004WO2004088321A1 Method for the enrichment of target cells by use of cbds
10/14/2004WO2004087963A1 Topoisomerase modulator assays
10/14/2004WO2004087960A2 Method and system for rapidly conferring a desired trait to an organism
10/14/2004WO2004087943A1 Method
10/14/2004WO2004087928A2 Transgenic plants expressing a gene encoding a xyloglucan endotransglycosylase
10/14/2004WO2004087927A1 Plants having modified growth characteristics and method for making the same
10/14/2004WO2004087925A1 Modified beta-lactamases and uses thereof
10/14/2004WO2004087918A2 Method for the in vivo modification of the synthesis activity of a metabolite by means of the modification of a gene the activity of which is not the original activity
10/14/2004WO2004087917A1 Thioredoxin modification
10/14/2004WO2004087909A1 Polynucleotide encoding 2-hydorxyisoflavanone dehydratase and application of the same
10/14/2004WO2004087907A2 Crystal structure of streptococcus undecaprenyl pyrophosphate synthase and uses thereof
10/14/2004WO2004087906A1 Crystal structure of 3',5'-cyclic nucleotide phosphodiesterase 1b (pde1b) and uses thereof
10/14/2004WO2004087905A2 Protein tyrosine phosphatase and inhibitors thereof
10/14/2004WO2004087903A2 Novel proteins homologous to kinase suppressor of ras
10/14/2004WO2004087902A2 Novel plant acyltransferases specific for long-chained, multiply unsaturated fatty acids
10/14/2004WO2004087901A2 Brain-localized protein kinases homologous to homeodomain-interacting protein kinases
10/14/2004WO2004087895A1 tdcBC/pckA GENE-INACTIVATED MICROORGANISM AND METHOD OF PRODUCING L-THREONINE USING THE SAME
10/14/2004WO2004087879A2 Pufa polyketide synthase systems and uses thereof
10/14/2004WO2004087868A2 Dna polymerase fusions and uses thereof
10/14/2004WO2004087867A2 Methods for the identification of inhibitors of serine acetyltransferase activity in plants
10/14/2004WO2004087862A2 Tak1-mediated inhibition of osteogenesis
10/14/2004WO2004087861A2 Biological contamination-removal method
10/14/2004WO2004087750A2 A method for oxygen regulated production of recombinant staphylokinase
10/14/2004WO2004087736A2 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip)
10/14/2004WO2004087057A2 Methods for inhibition of angiogenesis
10/14/2004WO2004087046A2 TREATMENT OR PREVENTION OF cGMP-DEPENDENT PATHOPHYSIOLOGY WITH A MUTANT VARIANT OF SOLUBLE GUANYLYL CYCLASE
10/14/2004WO2004076615A9 Immunomodulating probiotic compounds
10/14/2004WO2004072232A9 Covalent tethering of functional groups to proteins
10/14/2004WO2004058186A3 Formulations for pulmonary delivery
10/14/2004WO2004057003A3 Method for producing aminoacids
10/14/2004WO2004053082A3 Organogenic transformation and regeneration
10/14/2004WO2004044192A3 Plasmodium protozoa phosphodiesterase, nucleic acid encoding the phosphodiesterase, and treatment of malaria using inhibitor of the phosphodiesterase
10/14/2004WO2004042076A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a)
10/14/2004WO2004029232A3 Acc gene
10/14/2004WO2004028341A3 Susceptibility gene for human stroke; methods of treatment
10/14/2004WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor
10/14/2004WO2004018695A3 Method for producing ketocarotinoids in plant fruit
10/14/2004WO2004017749A3 Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed